After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights

After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights

Submitted by admin on August 16, 2022 - 12:36pm
Source: 
Fierce Pharma
News Tags: 
Gilead Sciences
Immunomedics
Trodelvy
Everest Medicines
Headline: 
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
snippet: 

When Gilead Sciences acquired Immunomedics in 2020, another company owned certain rights to the deal's crown jewel Trodelvy. Now, Gilead thinks it’s time to take it back.

Do Not Allow Advertisers to Use My Personal information